New era for management of chronic hepatitis C virus using direct antiviral agents: A review

by Tamer Elbaz, Mohamed El-Kassas, Gamal Esmat
Published 2015-05-01

Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma: The debate continues – A mini-review

by Mohamed El Kassas, Tamer Elbaz, Mohamed Salaheldin, Lobna Abdelsalam, Ahmed Kaseb, Gamal Esmat
Published 2019-05-01

Endoscopic band ligation combined with argon plasma coagulation versus band ligation alone for eradication of esophageal varices

by Ali Ghweil, Shamarden Bazeed, Mohamed Alsenbsy, Heba Saleh, Mohamed El Kassas, Bahaa Abbas, Gamal Esmat, Hamdy Moustafa
Published 2016-01-01

Survival benefits of adding simvastatin to standard therapy for secondary prevention of bleeding esophageal varices in patients with hepatitis C-related liver cirrhosis

by Helmy Elshazly, Hasan Zaghlah, El-Sayed Tharwa, Ahmed Abuamer, Dina Nor-Eldin, Reem El Sheemy, Mohamed El Kassas
Published 2021-09-01

Prospective comparison of transient elastography and liver biopsy for the assessment of fibrosis in chronic hepatitis C infection

by Ahmed H.K. Abdelmaksoud, Mohamed El_Sayed Taha, Mohamed El Kassas, Reem E. Mahdy, Gamal El-Din Esmat Mohamed, Hany Ahmed Samy
Published 2015-06-01

Caspase recruitment domains. New potential markers for diagnosis of hepatocellular carcinoma associated with HCV in Egyptian patients

by Abdel-Rahman Zekri, Mohamed El-Kassas, Yasmin Saad, Abeer Bahnassy, Hany Khatab Sameh Seif El-Din, Samar K. Darweesh, Hanan Abdel Hafez, Gamal Esmat
Published 2013-09-01

Management of liver disease patients in different clinical situations during COVID-19 pandemic

by Samy Zaky, Mohamed Alboraie, Mohamed El Badry, Mohamed A. Metwally, Ahmed Abdelaziz, Yasser Fouad, Sherief Abd-Elsalam, Abdelmajeed Mahmoud, Gamal Shiha, Amin Abdel Baki, Mohamed El Kassas, Gamal Esmat
Published 2021-03-01

acNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation study

by Xi-Xi Wu, Kenneth I. Zheng, Jérôme Boursier, Wah-Kheong Chan, Yusuf Yilmaz, Manuel Romero-Gómez, Mohamed El Kassas, Giovanni Targher, Christopher D. Byrne, Zhi-Ming Huang, Ming-Hua Zheng
Published 2021-11-01

Correction to: Prevalence of prolonged QT interval in patients with HCV-related chronic liver disease

by Ahmed E. Gaafar, Amr Abd El-Aal, Mohamed Alboraie, Housam M. Hassan, Adel ElTahan, Yasser AbdelRahman, Mohamed-Naguib Wifi, Dalia Omran, Shimaa Afify Mansour, Waleed M. Hassan, Magdy Ismail, Mohamed El Kassas
Published 2019-10-01

Prevalence of prolonged QT interval in patients with HCV-related chronic liver disease

by Ahmed E. Gaafar, Amr Abd El-Aal, Mohamed Alboraie, Housam M. Hassan, Adel ElTahan, Yasser AbdelRahman, Mohamed-Naguib Wifi, Dalia Omran, Shimaa Afify Mansour, Waleed M. Hassan, Magdy Ismail, Mohamed El Kassas
Published 2019-09-01

MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection.

by Abdel-Rahman N Zekri, Enas Reda El-Sisi, Amira Salah El-Din Youssef, Mahmoud M Kamel, Auhood Nassar, Ola Sayed Ahmed, Mohamed El Kassas, Ahmed Barakat Barakat, Alaa Ismail Abd El-Motaleb, Abeer A Bahnassy
Published 2018-01-01

Promotor methylation: Does it affect response to therapy in chronic hepatitis C (G4) or fibrosis?

by Abdel-Rahman N. Zekri, M.Sc., Ph.D., Ahmed M. Raafat, Suzan Elmasry, Abeer A. Bahnassy, Yasmin Saad, Hamed A. Dabaon, Mohamed El-Kassas, Hend I. Shousha, Auhood A. Nassar, Mohamed Ale EL-Dosouky, Nehal Hussein
Published 2014-09-01

Retreatment of chronic hepatitis C patients who failed previous therapy with directly acting antivirals: A multicenter study

by Mohamed El Kassas, Mohamed Alboraie, Mohamed El Badry, Naglaa Youssef, Heba Omar, Reem Y. El Sheemy, Amira Al Balakosy, Ossama Ashraf Ahmed Mohamed, Gina Gamal Naguib Meleak, Hany Dabbous, Mohamed Hassan Ahmed Fouad, Mohamed-Naguib Wifi, Samy Zaky, Marwa Tahoon, Adel El Tahan, Fathiya El-Raey, Sameera Ezzat, Wahid Doss
Published 2020-07-01

Assessing the impact of COVID-19 on liver cancer management (CERO-19)

by Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, Jean-Charles Nault, Gonzalo Sapisochin, Lorenza Rimassa, Bruno Sangro, Jordi Bruix, Marco Sanduzzi-Zamparelli, Wacław Hołówko, Mohamed El Kassas, Tudor Mocan, Mohamed Bouattour, Philippe Merle, Frederik J.H. Hoogwater, Saleh A. Alqahtani, Helen L. Reeves, David J. Pinato, Emmanouil Giorgakis, Tim Meyer, Gerda Elisabeth Villadsen, Henning Wege, Massimiliano Salati, Beatriz Mínguez, Giovan Giuseppe Di Costanzo, Christoph Roderburg, Frank Tacke, María Varela, Peter R. Galle, Mario Reis Alvares-da-Silva, Jörg Trojan, John Bridgewater, Giuseppe Cabibbo, Christian Toso, Anja Lachenmayer, Andrea Casadei-Gardini, Hidenori Toyoda, Tom Lüdde, Rosanna Villani, Ana María Matilla Peña, Cassia Regina Guedes Leal, Monica Ronzoni, Manuel Delgado, Christie Perelló, Sonia Pascual, José Luis Lledó, Josepmaria Argemi, Bristi Basu, Leonardo da Fonseca, Juan Acevedo, Alexander R. Siebenhüner, Chiara Braconi, Brandon M. Meyers, Alessandro Granito, Margarita Sala, Carlos Rodríguez-Lope, Lorraine Blaise, Manuel Romero-Gómez, Federico Piñero, Dhanny Gomez, Vivianne Mello, Rogerio Camargo Pinheiro Alves, Alex França, Fernanda Branco, Giovanni Brandi, Gustavo Pereira, Susanna Coll, Maria Guarino, Carlos Benítez, Maria Margarita Anders, Juan C. Bandi, Mercedes Vergara, Mariona Calvo, Markus Peck-Radosavljevic, Ignacio García-Juárez, Vincenzo Cardinale, Mar Lozano, Martina Gambato, Stefano Okolicsanyi, Dalia Morales-Arraez, Alessandra Elvevi, Alberto E. Muñoz, Alberto Lué, Massimo Iavarone, Maria Reig
Published 2021-06-01